📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MDM2 Antagonist Idasanutlin Reduces HDAC1/2 Abundance and Corepressor Partners but Not HDAC3. (2024)

First Author: Smalley JP

Attributed to: Bilateral BBSRC-SFI: Understanding the impact of divergent Sin3A/HDAC1 complex assemblies in gene regulation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsmedchemlett.3c00449

PubMed Identifier: 38229760

Publication URI: http://europepmc.org/abstract/MED/38229760

Type: Journal Article/Review

Volume: 15

Parent Publication: ACS medicinal chemistry letters

Issue: 1

ISSN: 1948-5875